Hussein A. Abbas

Hussein A. Abbas is an Assistant Professor at The University of Texas MD Anderson Cancer Center, where he specializes in hematology and oncology. His research focuses on the molecular pathogenesis of acute myeloid leukemia (AML) and other myeloid neoplasms, with particular emphasis on complex karyotypes, chromosome 5q deletions, and chromosome 7 deletions. His recent work includes integrated genomic analyses of core-binding factor AML treated with FLAG-based therapy, venetoclax-based regimens for therapy-related AML, and novel therapeutic approaches such as glutaminase-free asparaginase and MERTK-targeting agents. He has published extensively in leading journals including Blood, Blood Cancer Discovery, and HemaSphere, and his research bridges translational immunology and cancer biology to improve outcomes in malignant blood disorders.